| Author/Editor | Kraigher, Alenka | |
| Title | Zakonske osnove presejalnega testiranja v nosečnosti | |
| Translated title | Legislation on screening in pregnancy | |
| Type | članek | |
| Source | Med Razgl | |
| Vol. and No. | Letnik 45, št. Suppl 3 | |
| Publication year | 2006 | |
| Volume | str. 11-6 | |
| Language | slo | |
| Abstract | Screening program in pregnancy for an early detection of hidden diseases and vertically transmitted infections is a very important tool. The implementation of screening program in national health preventive programs requires a thorough base and should contain an estimation of their conformity to the principles with regards to the diseases and methods of choice. Permanent evaluation regarding health efficiency and quality must also accompany considerations about possible ethic and psychological consequences. Ultimate goal of a new screening program has to be very clear. Screening should be approved by a competent national body and authority because sustainability of funds and human resources is of great importance. Very important is to assure legal base for safety and privacy of personal data, consent and research ethics. Future research and development in the field of population screening would bring more knowledge for needs and standards as a result of medical-legal and ethics approaches. | |
| Summary | Za ugotavljanje prisotnosti okužb oz. zgodnje ugotavljanje občutljivosti za določene okužbe pri nosečnicah, ki se lahko vertikalno prenašajo na otroka, so pomembni presejalni testi. Uvedba presejalnega programa v nacionalni zdravstveni preventivni program zahteva natančno utemeljitev in pripravo ob upoštevanju pravil glede izbire bolezni in metode. Nenehno vrednotenje in spremljanje kakovosti in učinkovitosti presejanja s ciljem izboljšanja je izrednega pomena zaradi ugotovitve možnih etičnih in psiholoških posledic. Cilji presejanja morajo biti jasno opredeljeni v smislu končnega zdravstvenega rezultata in dobrobiti. Za izvajanje presejanja je potrebno dolgoročno zagotoviti stabilno financiranje in kadrovsko zmogljivost, zato morajo biti ti programi sprejeti s širokim odobravanjem stroke in oblasti. Oblikovati je treba pravno podlago glede varovanja zasebnosti, privolitve in raziskovalne etike. Prihodnja poglobljena preučevanja in razprave bodo podale usmeritve glede potreb po presejanju ciljnih skupin prebivalstva in standarde za programe, ki bodo rezultat sodelovanja medicine, etike in prava. | |
| Descriptors | PREGNANCY COMPLICATIONS, INFECTIOUS HEPATITIS B TOXOPLASMOSIS SYPHILIS MASS SCREENING LEGISLATION, MEDICAL |